Viewing Study NCT02205333


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2025-12-27 @ 11:35 PM
Study NCT ID: NCT02205333
Status: TERMINATED
Last Update Posted: 2017-06-28
First Post: 2014-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Sponsor: MedImmune LLC
Organization: